Год: 2004
Язык: Russian
Этот материал также есть на других языках: Арабский Английский Французский Испанский Китайский (упрощенный)
Автор(ы): World Federation of Hemophilia
Формат: Документ
Also Available In: Japanese
Treating people with hemophilia with safe, regulated plasma-derived factor concentrate directly reduces the social and economic impact of this bleeding disorder on the patient as well as the amount of long-term support required from family, community, and government.
A summary of discussions held at the Eleventh WFH Global Forum on Research and Treatment Products for Bleeding Disorders which
This module was presented by Susan Cutter at the Virtual Workshop for Psychosocial Professionals in Europe on June 23, 2021.
Listen to this 2-hour webinar presented on April 22, 2021 to learn about global topics related to bleeding disorders. The
This illustrated schematic demonstrates the normal process of blood clotting, how it is diminished when a clotting factor is lacking,
This resource has also been translated into the following languages, with permission from the WFH, by NMOs: Polish Desmopressin (DDAVP) may
Also Available In: Japanese A national tender system is a cost-effective system for the purchase of products or services, such
© 2025 World Federation of Hemophilia
